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Selenium, an essential micronutrient known for its cancer preven-
tion properties, is incorporated into a class of selenocysteine-
containing proteins (selenoproteins). Selenoprotein H (SepH) is a
recently identified nucleolar oxidoreductase whose function is not
well understood. Here we report that seph is an essential gene
regulating organ development in zebrafish. Metabolite profiling
by targeted LC-MS/MS demonstrated that SepH deficiency impairs
redox balance by reducing the levels of ascorbate and methionine,
while increasing methionine sulfoxide. Transcriptome analysis
revealed that SepH deficiency induces an inflammatory response
and activates the p53 pathway. Consequently, loss of seph renders
larvae susceptible to oxidative stress and DNA damage. Finally, we
demonstrate that seph interacts with p53 deficiency in adulthood
to accelerate gastrointestinal tumor development. Overall, our
findings establish that seph regulates redox homeostasis and sup-
presses DNA damage. We hypothesize that SepH deficiency may
contribute to the increased cancer risk observed in cohorts with
low selenium levels.
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Selenium is an essential micronutrient that has been impli-cated in cancer chemoprevention and is thought to delay the
severity of cardiovascular and neurologic disorders (1). The bi-
ological properties of selenium are mediated by a diverse group
of selenocysteine (Sec)-containing selenoproteins (2). Sec is in-
corporated into protein in response to the UGA opal codon in a
unique context in which the 3′ UTR of the gene contains a Sec
insertion sequence (SECIS) element (3, 4). The human seleno-
proteome includes five glutathione peroxidases (GPX1-4, 6),
three thioredoxin reductases (TXNRD1-3), and one methionine
sulfoxide reductase (MSRB1) that act in concert to provide an-
tioxidant defense (2). The selenoproteome also includes three
iodothyronine deiodinases (DIO1-3) that control thyroid hor-
mone metabolism and two selenoproteins that are involved in
selenoprotein synthesis (SPS2) and transport (SELP). In con-
trast, little is known regarding the function of the other 11 human
selenoproteins (SELW, SELT, SELH, SELV, SELI, SEP15,
SELM, SELK, SELS, SELO, and SELN) (5).
Although selenium was originally considered a toxin, classic
work by Schwartz and Foltz showed that selenium prevents liver
necrosis in rats, suggesting that it is an essential micronutrient
(6). This essential role as a micronutrient during development
was subsequently recognized by the livestock industry and is now
widely known for human health (7). Genetic disruption of three
mammalian selenoproteins―GPX4, TXNRD1, and TXNRD2―
causes embryonic lethality (8–12) in murine models. SelP-deficient
mice exhibit impaired selenium transport from the liver to pe-
ripheral tissues and show growth retardation and impaired motor
coordination (13, 14). In contrast, mice deficient in Gpx1 (15),
Gpx2 (16), Gpx3 (17), MsrB1 (18), Sep15 (19), or SelM (20) are
viable, with more subtle defects, some of which only manifest in
the context of stress.
Epidemiologic surveys have shown that selenium deficiency
may be associated with an increased risk of certain types of cancer
(21, 22). For example, patients with cirrhosis (scarring) of the liver
have a high risk of developing liver cancer, and are typically de-
ficient in selenium (23–26). However, selenium supplementation
chemoprevention trials have provided mixed results, possibly re-
lated to a combination of unknown baseline selenium status and
genetic factors that modulate selenoprotein function (22). In vivo
cancer studies using transgenic mice have revealed that the role
of selenoproteins in tumorigenesis is context-dependent, both
preventing and promoting cancer (27, 28). The importance of
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selenium and selenoproteins in embryonic development and tu-
morigenesis underscores the need for a better understanding of
the biological function of the recently identified selenoproteins.
Here we show that seph (ortholog of human SELH) plays an
essential role in vertebrate organ development. Using unbiased
metabolomic and transcriptomic approaches, we found that SepH
deficiency alters redox homeostasis, provokes an inflammatory
response, and activates p53. SepH-deficient zebrafish larvae ex-
hibit an increased susceptibility to oxidative stress and DNA
damage. Loss of p53 partially mitigates the developmental defects
observed in seph mutants; however, loss of p53 function combines
with SepH haploinsufficiency in adulthood to accelerate gas-
trointestinal (GI) tumor development. Collectively, our results
establish that SepH regulates redox homeostasis and suppresses
DNA damage during development and tumorigenesis.
Results
seph Mutant Zebrafish Exhibit Defects in Organ Development. This
investigation was spurred by the isolation of a seph mutant from
a large-scale insertional mutagenesis screen (29). This seph
mutant was caused not by viral insertion into the coding region,
but rather by insertion into the 3′ UTR. Sequence analysis in-
dicated that the virus is inserted in the 3′ UTR upstream of the
regulatory SECIS element (Fig. 1 and Fig. S1A); therefore, we
infer that loss of function in seph mutants is caused by displace-
ment of the SECIS element and a consequent inability to read the
in-frame UGA codon as Sec. We found that seph expression,
present in the head region of wild type (WT) embryos, was com-
pletely absent in the seph mutant larvae at 3 dpf (Fig. S1B). This is
consistent with previous studies demonstrating that SELH (human
ortholog of seph) is among the most sensitive selenoprotein mRNAs
to changes in abundance in response to selenium status, owing to
the differences in Sec incorporation efficiency and nonsense-medi-
ated decay (30, 31).
Developmental defects in homozygous seph mutants begin to
manifest morphologically by 3 d postfertilization (dpf), and the
mutants lose viability by 12–14 dpf (Fig. 1B). At 5 dpf, seph
mutants exhibit craniofacial defects with smaller eyes (micro-
phthalmia), impaired yolk absorption, and an uninflated swim
bladder (Fig. 1C). To examine the effect of SepH deficiency on
endodermal organ development, we imaged seph mutants on
transgenic reporter fish, highlighting the liver and exocrine
pancreas [Tg(ela3l:GFP;fabp10a:dsRed)] at 5 dpf, which revealed
dramatically impaired liver and pancreas development (Fig. 1C).
Quantification of liver and pancreas fluorescence revealed that
the seph mutant liver was ∼40% smaller than WT liver, whereas
the pancreas was almost absent (Fig. 1 D and E). Similarly, we
assessed organ development in Tg(gata6:GFP), which highlights
endodermal organs, and Tg(fabp2:dsRed), which illuminates the
intestinal epithelium of larvae, and this confirmed that seph mu-
tants exhibit defects in intestinal development (Fig. S1 C and D).
To confirm that the loss of seph gene function induced by
disruption of the SECIS element is responsible for the devel-
opmental defects, we injected an antisense morpholino targeting
seph into WT embryos at the one-cell stage, which resulted in a
morphant phenotype that recapitulates the seph mutant (Fig. S1E).
Whole-mount in situ hybridization (WISH) analysis for fabp10a,
trypsin, and fabp2 expression in seph morphants and mutants
compared with WT larvae at 72 hpf revealed that seph plays a
critical role in liver, pancreas, and gut formation (Fig. S1 E and
F). To verify that loss of seph is responsible for the mutant
phenotype, we performed a rescue experiment injecting seph
mutant embryos with mRNA encoding GFP-labeled murine
selenoprotein h (selh). We found that expression of either N- or
C-terminal SelH-GFP fusion constructs (GFP-SelHSec38Cys or
Fig. 1. seph mutant zebrafish exhibit defects in organ development. (A) Schematic illustrating the nature of the seph mutant. (B) Survival of WT and ho-
mozygous seph mutant larvae over time. n = 160 larvae. (C) Morphological assessment and fluorescent imaging (lateral and ventral views) of WT and seph
mutant larvae on a Tg(ela3l:GFP;fabp10a:dsRed) background by confocal tomography at 5 dpf. Liver volume: WT, 3.09e6 μm3; seph, 1.69e6 μm3. Pancreas
volume: WT, 2.79e6 μm3; seph, undetectable. (Scale bar: 100 μm.) (D) Quantitative analysis of fluorescent liver area in WT and sephmutant larvae at 5 dpf. n = 16.
****P < 0.0001. (E) Quantitative analysis of fluorescent pancreas area in WT and seph mutant larvae at 5 dpf. n = 16. ****P < 0.0001.
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SelHSec38Cys-GFP) (32, 33) was sufficient to rescue the seph
mutant phenotype in the vast majority of injected embryos (Fig.
S1 G and H). Taken together, these experiments demonstrate
that seph is an essential gene that plays a key role in endodermal
organ development.
Metabolomic Characterization of seph Mutant Larvae Reveals That
SepH Modulates Redox Homeostasis. Given the central role of many
selenoproteins in oxidative metabolism, we aimed to characterize
the metabolic status of seph mutant larvae. Polar metabolites were
extracted from WT and homozygous seph mutant larvae at 5 dpf
and analyzed by targeted LC-MS/MS via selected reaction moni-
toring (SRM) (34). Hierarchical clustering based on metabolite
abundance showed significant changes in steady-state levels of a
small fraction of themetabolites that were enriched (fold enrichment
represents the normalized number of metabolites overrepresented
from a predefined metabolic pathway) in the urea cycle, pyrimidine
biosynthesis, and methionine (Met) metabolism (Fig. 2 A and B). No
significant changes in the abundance of reducedor oxidized glutathione
were observed (Fig. S2A). seph mutants had reduced NAD+:NADH
andNADP+:NADPH ratios, due inmost part to the large reductions
in the abundance of NAD+ and NADP+, respectively (Fig. 2C and
Fig. S2B). Interestingly, the sephmutants showed a reduction inMet
levels and a concomitant increase in the abundance of Met sulfox-
ide (MetSO) (Fig. 2D). Consequently, the Met:MetSO redox status
was substantially disrupted in the seph mutant larvae (Fig. 2E).
Furthermore, seph mutants exhibited a dramatic reduction in the
abundance of the antioxidant ascorbic acid (vitamin C) (Fig. 2F).
Given the imbalance of the Met:MetSO redox state, we measured
MetSO reductase (Msr) activity (both MsrA and MsrB) in larval
lysates. These analyses showed no difference between WT and seph
mutants (Fig. S2C), suggesting elevatedMet oxidation in themutant.
Collectively, these studies illustrate that SepH plays an important
role in maintaining specific aspects of redox homeostasis related to
ascorbate and Met metabolism.
SepH-Deficient Larvae Are Prone to Oxidative Stress. To further
assess the role of SepH in regulating reactive oxygen species
during development, we visualized H2O2 generation in vivo using
the boronate-based H2O2 probe, PF2. PF2 fluorescence was in-
creased in homozygous seph mutant larvae at 5 dpf (Fig. 3 A and
B). Fluorescence intensity was heterogeneous in distribution, but
most apparent in the endodermal and head regions. seph mu-
tants were extremely sensitive to menadione-induced oxidative
stress, resulting in axis curvature and global edema (Fig. 3 C and
D). Taken together, these studies demonstrate that seph mutants
have impaired antioxidant defense.
Transcriptomic Profiling Reveals That SepH Deficiency Provokes an
Inflammatory Response and Activates the p53 Pathway. To deter-
mine whether SepH deficiency causes a transcriptional response
that contributes to the developmental phenotype, we performed
global RNAseq on WT and homozygous seph mutant larvae at
5 dpf. Transcriptomic profiling of differentially expressed genes
revealed that SepH deficiency causes widespread changes in
gene expression (Fig. 4A and Fig. S3A). Transcriptome profiling
also further determined the extent of organ defects, including
severe reductions in endoderm/hepatic progenitors (sox17, prox1)
and hepatic (fabp10a), intestinal (fabp2), and pancreatic (trypsin)
transcripts, with no changes in kidney (cdh17)- or vessel (kdrl)-
related transcripts (Fig. S3B). Supporting the metabolic data
indicating defects in Met metabolism, Gene Set Enrichment
Analysis (GSEA) identified that seph mutants express a gene set
associated with Met deprivation (Fig. S3C). Interestingly, GSEA
also revealed that SepH deficiency enhances the expression of
inflammatory response genes, including tnfa, il-1b, il-11a, socs3b,
and lifrb (Fig. 4 B and C and Fig. S3D). seph mutants also
demonstrated a strong induction of p53 target genes, including
tp53, mdm2, ccng1, and rps27l (Fig. 4D and Fig. S3E). The re-
sults of our transcriptome analysis support the idea that loss of
SepH provokes an inflammatory response and activates the
p53 pathway.
SepH-Deficient Larvae Are Sensitive to DNA Damage. Having ob-
served that SepH deficiency activates a transcriptional p53 response,
we tested whether p53 activation contributes to the developmental
Fig. 2. Metabolomics reveals that SepH deficiency
modulates redox homeostasis. (A) Clustergram analysis
of polar metabolite abundance in WT and sephmutant
larvae at 5 dpf as determined by LC-MS/MS via SRM
analysis. n = 3. P < 0.05. (B) Metabolite set enrichment
of polar metabolites in WT and seph mutant larvae
as determined by SRM analysis. (C ) Steady-state
ratio of redox-related metabolites NAD+:NADH,
and NADP+:NADPH in WT and seph mutant larvae
at 5 dpf. (D) Steady-state abundance of Met (re-
duced) and MetSO (oxidized) in WT and seph mu-
tant larvae at 5 dpf. n = 3. *P < 0.05. (E) Met:MetSO
ratio in WT and seph mutant larvae at 5 dpf. n = 3.
*P < 0.05. (F) Steady-state abundance of ascorbic
acid in WT and seph mutant larvae at 5 dpf. n = 3.
*P < 0.05.
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phenotype. Immunoblot analysis demonstrated dramatically
elevated p53 levels in seph mutant larvae (Fig. 5A). To ex-
amine whether the cell cycle is affected, we performed whole-
mount immunohistochemistry probing bromo-deoxyuridine
(BrdU) incorporation, and found that seph mutants incorporate
lower levels of BrdU (Fig. S4A). Consistent with cell cycle de-
fects, FACS analysis demonstrated that seph mutants exhibit an
increased number of cells in the G0 phase and a decreased
number of cells in the S or G2/M phase (Fig. S4B).
We next examined the response of seph mutants to DNA
damage after exposure to UV irradiation (200 J/m2) and found
that they were highly sensitized compared with WT larvae, with
50% mortality at 2 d postexposure (dpe) (Fig. 5B). Consistent
with this notion, SepH-deficient larvae also were very sensitive to
exposure to the DNA-damaging agent camptothecin (1 μM),
with an 80% drop in survival at 2 dpe (Fig. 5C). Taken together,
these studies reveal that seph mutant larvae exhibit cell cycle
defects and are prone to DNA-damaging agents.
Given the involvement of p53 in the defects observed in seph
mutant larvae, we tested whether the seph mutant phenotype
persists in the absence of p53. Crossing seph mutants onto a
tp53M214K mutant background partially rescued the seph mutant
phenotype. At the gene expression level, the loss of p53 in tp53;
seph compound mutant larvae suppresses activation of p53 target
genes rps27l and mdm2; however, we still observed activation of
inflammatory genes, such as tnfa and il11a (Fig. S4C). At the
morphological level, the craniofacial, eye, and endodermal organ
defects were less severe in tp53;seph compound mutant larvae
compared with seph mutants (Fig. 5D). Deeper examination by
WISH analysis demonstrated that the loss of p53 rescued liver
and, to a lesser effect, gut development in tp53;seph compound
mutant larvae, but had no effect on exocrine pancreas develop-
ment (Fig. 5E and Fig. S4D).
To examine the brain defects, we determined the expression of
the neuron-specific gene elavl3 by WISH and quantitative PCR
(qPCR) and observed a dramatic reduction in seph mutants
compared with WT larvae, and this reduction was not altered in
tp53;seph compound mutant larvae (Fig. S5 A and B). Minor de-
fects in cartilage development also were apparent in both seph and
tp53;seph compound mutant larvae at 5 dpf (Fig. S5A). Histolog-
ical analysis revealed that seph mutants exhibit hepatocyte bal-
looning and signs of cell death, which are markedly reduced in
tp53;seph compound mutant larvae at 5 dpf (Fig. 5D). Further
immunohistochemical analysis of the sephmutants established that
cell proliferation (PCNA) in the liver is decreased concomitant
with an increase in apoptosis (cleaved caspase-3), and that these
effects are partially rescued in the tp53;seph compound mutant
larvae (Fig. S5 C and D). Taken together, these studies reveal
that loss of tp53 partially mitigates the developmental defects
observed in seph mutant larvae.
Fig. 3. SepH deficient larvae are prone to oxidative
stress. (A) Fluorescent detection of H2O2 (PF2 fluo-
rescence) in WT and seph mutant larvae at 5 dpf.
(Scale bar: 200 μm.) (B) Quantification of H2O2 in WT
and seph mutant larvae at 5 dpf. n = 5. **P < 0.01.
(C) Morphological assessment of WT and seph mu-
tant larvae exposed to menadione (1 μM) from 3 to
5 dpf. (Scale bar: 200 μm.) (D) Quantification of phe-
notype (unaffected, moderate, or severe) observed
following menadione (1 μM) exposure from 3 to
5 dpf. Moderately affected larvae include minor
defects, such as edema and tail curling, whereas se-
verely affected larvae include major defects, such as
widespread tissue necrosis (loss of transparency).
Fig. 4. Transcriptomic profiling reveals that SepH
deficiency provokes an inflammatory response and
activates the p53 pathway. (A) Heatmap of statisti-
cally significant differential gene expression as de-
termined by RNAseq between WT and seph mutant
larvae at 5 dpf. n = 4. P < 0.05. (B) GSEA showing
that the SepH deficiency is highly enriched in genes
associated with an inflammatory response signature.
ES, 0.67; NES, 2.41. P < 0.05. (C) qPCR expression
analysis of specific genes associated with an in-
flammatory response (tnfa, il11a, socs3b, and lifrb) in
WT and sephmutant larvae at 5 dpf. n = 3. *P < 0.05;
***P < 0.001. (D) qPCR expression analysis of specific
genes associated with p53 activation (mdm2, ccng1,
tp53, and rps27l) in WT and seph mutant larvae at
5 dpf. n = 3. *P < 0.05; **P < 0.01; ***P < 0.001.
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seph Genetically Interacts with p53 Deficiency to Accelerate GI Tumor
Formation. Having shown that SepH deficiency disrupts redox
homeostasis, provokes an inflammatory response, and activates
p53 in development, we next examined whether SepH plays an
important role in suppressing tumor development. We exposed
progeny of tp53−/−;seph+/− fish to the carcinogen dimethyl-
benzanthracene (DMBA) at 3 wk postfertilization and followed
tumor development in the fish over a period of 1 y (Fig. 6A). In
our analysis, we focused on GI tumor development, which be-
came readily apparent because GI tumor-bearing fish have dis-
tended abdomens and on dissection reveal tumors that can be
confirmed histologically and segregated by genotype (Fig. 6B).
We analyzed GI tumor-free survival in this cohort of fish and
found that SepH deficiency (heterozygous mutant) significantly
accelerated tumor onset (Fig. 6C). By the end of the 1-y inves-
tigation, 29 of 58 (50%) tp53−/−;seph+/− fish harbored tumors,
compared with 5 of 23 (22%) p53−/− fish (P = 0.0344). Histo-
logical analysis of the tumors that developed identified 52% of
the tp53−/−;seph+/− tumors as being of hepatic origin and 28% as
being of pancreatic origin (Fig. 6D). Most of the liver tumors
were hepatocellular carcinomas (HCCs) (Fig. S6A), whereas the
majority of the pancreatic tumors were pancreatic acinar cell
carcinomas (PACCs) (Fig. 6E and Fig. S6B). Here 21% of the
tumors in the tp53−/−;seph+/− fish and 20% of the tumors in the
tp53−/− fish were malignant spindle cell neoplasms, most likely
representing either malignant mixed neoplasms of the intestine
and/or malignant peripheral nerve sheath tumors (MPNSTs)
(Fig. 6E and Fig. S6C). Taken together, these studies show that
loss of seph synergizes with loss of tp53 and the carcinogen
DMBA in promoting carcinogenesis.
Discussion
The micronutrient selenium plays an essential role in human
health, and its effects are mediated by incorporation, in the form
of the 21st amino acid Sec, into 25 proteins that compose the
human selenoproteome. Despite the extensive functional infor-
mation for some members of the selenoproteome, such as thi-
oredoxin reductases, glutathione peroxidases, thyroid hormone
deodinases, and MetSO reductases, relatively little is known
about several more recently identified selenoproteins, which has
spurred inquiry into their biological functions (2). SepH is one
such protein of unknown function, which is conserved in verte-
brates, and its functional homologs are present across metazoa.
Because of this conservation, zebrafish represent a particularly
Fig. 5. sephmutants are sensitive to DNA damage. (A) Immunoblot analysis of p53 expression in WT and sephmutant larvae at 5 dpf. (B) Survival of WT and
seph mutant larvae 2 dpe to UV irradiation (200 J/m2, 7 dpf). n = 7. ****P < 0.0001. (C) Survival of WT and seph mutant larvae 2 dpe to camptothecin (1 μM).
n = 10. ****P < 0.0001. (D) Morphological and histological analysis of WT, seph−/− and tp53−/−;seph−/− mutant larvae at 5 dpf. The yellow dashed region
represents the liver. The region of histology showing the larval liver is shown in the zoomed images. [Scale bars: 200 μm (brightfield; BF) and 50 μm (histology;
H+E).] (E) Quantitative analysis of liver, pancreas, and gut area in WT, seph−/−, and tp53−/−;seph−/− mutant larvae at 5 dpf. n > 8. *P < 0.05; ****P < 0.0001.
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attractive model for examining SepH functions. In this study, we
found that seph mutants exhibited impaired organ development
and failed to survive into adulthood. seph mutants were suscep-
tible to oxidative stress and showed defects in maintaining the
redox state of Met and ascorbate. seph mutant larvae exhibited a
sustained inflammatory response and activation of p53, which
contributed to the embryonic phenotype. seph-haploinsufficient
adult fish were more prone to developing GI tumors. Collec-
tively, these studies identify unique aspects of SepH function in
regulating organ development and tumorigenesis by maintaining
redox homeostasis and suppressing DNA damage (Fig. S7). In
light of these studies, we hypothesize that SepH deficiency is an
important factor contributing to human pathophysiology associ-
ated with selenium deficiency.
Biological Features of SepH. SepH is a recently identified 14-kDa
thioredoxin fold-like protein with a conserved CXXU motif (5).
Initial biochemical studies have shown that SepH is a nucleolus-
localized oxidoreductase with glutathione peroxidase activity and
a DNA-binding AT hook domain (32, 33). In vitro studies have
shown that selenium depletion significantly decreases seph mRNA
abundance (35), whereas selenite exposure up-regulates seph
mRNA abundance (36). Selenium status tightly regulates seph
mRNA abundance in mice to a greater extent than most other
selenoproteins (37); for example, a selenium-deficient diet was
found to cause a 60% reduction in seph mRNA abundance in
murine liver, kidney, intestine, and splenic leukocytes owing
to nonsense-mediated decay (37–40). Recent elegant studies
reported by the Hatfield and Howard laboratories used ribosome
profiling to reveal that dietary selenium differentially regulates
selenoprotein expression in the liver, with gpx1, sepw1, and seph
being the most sensitive to dietary selenium (30). In vivo expres-
sion studies in zebrafish have shown that seph mRNA is localized
to proliferative zones of the central nervous system and brachial
arches over the first 2 dpf (41). Parallel studies examining the
Drosophila homolog of seph, known as BthD, have shown that the
protein is expressed in the salivary gland during embryogenesis
and in the adult ovary (42). Taken together, these studies highlight
the integral role of selenium in regulating SepH abundance.
No studies of genetic SepH deficiency in vertebrate models
have been reported to date, and the majority of the functional
studies examining the biological role of SepH have been per-
formed in cell culture. Overexpression of SEPH in cultured cells
up-regulates enzymes associated with de novo glutathione syn-
thesis, providing resistance to glutathione depletion (33). In a
similar manner, SEPH overexpression protects cells from ultra-
violet b (UV-B) irradiation by suppressing p53 activation (43, 44).
At the molecular level, up-regulation of SEPH triggers an AKT-
PKA-CREB pathway that culminates in the activation of PGC1α
and NRF1, which stimulates mitochondrial biogenesis, leading
to enhanced oxygen consumption and respiration (44–46). Con-
versely, knockdown of SEPH expression renders cancer cells
Fig. 6. seph genetically interacts with p53 deficiency to accelerate GI tumor formation. (A) Scheme illustrating the protocol used to study DMBA-induced
tumorigenesis. (B) Example of a GI tumor in a tp53−/−;seph+/− fish exposed to DMBA. (Scale bar: 2 mm.) (C) Kaplan–Meier analysis of Tumor-free survival in
tp53−/− and tp53−/−;seph+/− fish exposed to DMBA. n > 25 fish. P = 0.0344, Mantel–Cox log-rank test. (D) The incidence of pancreatic cancer, liver cancer,
intestinal cancer, and malignant spindle cell neoplasm in tp53−/− and tp53−/−;seph+/− fish exposed to DMBA. (E) Histological evaluation of GI tumors identified
in tp53−/−;seph+/− fish showing examples of PACC, HCC, and malignant spindle cell neoplasm (MSCN). (Scale bar: 100 μm.)
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susceptible to H2O2 (32). Recent work by Wu et al. (47) showed
that SEPH knockdown causes oxidative stress, which inhibits
proliferation and induces senescence in fibroblasts. In that study,
the authors found that H2O2 exposure in SEPH-deficient cells
provoked a sustained DNA damage response and senescence,
which was inhibited by loss of ATM or p53 function. In our pre-
sent study, we have defined the mechanism of SepH function in
vivo and discovered that it regulates redox homeostasis and inte-
grates a DNA damage response involving p53, which culminates in
organ defects during development and a susceptibility to tu-
morigenesis in adulthood.
The Nucleolus as a Stress Sensor. Our findings demonstrate that
deficiency of the nucleolar protein SepH provokes an inflam-
matory stress response and activates p53. Recent studies support
the emerging concept that the nucleolus acts as a stress sensor
facilitating p53 activation (48). Previous studies have proposed
the thought-provoking hypothesis that the diverse stimuli known
to activate p53 share the ability to disrupt nucleoli; these studies
show that DNA damage is not sufficient to activate p53, but
instead that p53 activation depends on nucleolar disruption (49,
50). A number of nucleolar proteins, including PICT (51), RPL5
(52), RPL6 (53), RPL11 (54-56), RPL23 (57), RPL26 (58, 59),
RPS6 (60), RPS7 (61, 62), RPS27L (63), NPM (64–66), and NCL
(58, 59), regulate the MDM2-p53 pathway. Recent studies have
shown that the 5S ribonucleoprotein particle (RNP), comprising
RPL5, RNP11, and 5S rRNA, regulates p53 on ribosomal stress
(67–69). Elegant studies using rps27l mutant mice have provided
evidence that RPS27L regulates p53-suppressing genomic insta-
bility and tumorigenesis (63). In the present study, we have dem-
onstrated that SepH deficiency leads to the induction of rps27l,
consistent with nucleoli disruption. Consequently, our work fur-
ther illuminates previous studies by providing evidence that SepH
acts as a redox sensor that integrates oxidative stress to the nu-
cleolar stress response pathway.
Zebrafish Models of Ribosomal and Nucleolar Stress. Zebrafish has
proven to be a useful model in which to examine the effect
of ribosomal biogenesis and nucleolar stress in vivo. Zebrafish
have been used to model several ribosomopathies, including
Diamond–Blackfan anemia (DBA), dyskeratosis congenital
(DC), and Shwachman–Bodian–Diamond syndrome (SBDS).
Studies have shown that loss of rps19 (70–74), rps24 (75), rps29
(76), rpl11 (77–79), and rpl22 (80) lead to hematopoietic defects
reminiscent of DBA. In many cases, the DNA damage response
contributes to p53 activation in zebrafish models of DBA (71).
Defects in genes linked to DC, such as nop10, lead to a p53-de-
pendent loss of hematopoietic stem cells (81). The gene responsible
for SBDS, which regulates ribosomal biogenesis, plays an essential
role in pancreas development (82). Furthermore, ribosomal pro-
teins are often enriched in endodermal organs, and many are re-
quired for pancreas development (83). For example, the nucleolar
protein Nom1 plays a critical role in ribosomal biogenesis and
pancreas development (84). The ribosomal biogenesis factors Bms1
and Wdr43 cause tissue-specific defects in endodermal and neural
crest development, respectively (85, 86). Heath et al. (87) recently
reported that loss of a critical component of the small subunit
processome, pw2h, causes defects in ribosome biogenesis, leading
to impaired organ development and induction of autophagy as a
survival response. Groundbreaking work by Amsterdam et al. (88)
has revealed that many genes encoding components of the ribo-
some act as haploinsufficient tumor suppressors in zebrafish. Fol-
low-up studies have revealed that the MPNSTs that form from a
loss of ribosomal genes exhibit a loss of p53 expression and are
highly aneuploid (89–91). Recent work by Provost et al. (92)
showed that ribosomal gene rpl36 restrains KrasG12V-induced
pancreatic cancer. Our study provides a different angle on the
field by establishing a nucleolus-localized selenoprotein, SepH,
which plays a critical role in regulating the nucleolar stress re-
sponse in development and cancer. Taken together, these studies
highlight the advantages of zebrafish as a model system for
studying ribosome and nucleolar biology in the context of de-
velopment and cancer.
Selenoproteins Play Essential Roles in Tissue Homeostasis and Cancer.
Our findings provide evidence that SepH exhibits a tumor-
suppressor function in the context of carcinogen-induced tu-
morigenesis. The tumor-suppressive activity of SepH is consis-
tent with its role in regulating redox homeostasis, inflammation,
and DNA damage during embryonic development. SepH de-
ficiency collaborates with a loss of p53 function to accelerate GI
tumorigenesis. Interestingly, we found that SepH-deficient fish
exhibited induction of inflammatory genes, such as tnfa and il11a,
even in the absence of p53. Given the recently reported tumor-
promoting effects of tnfa (93, 94) and il11 (95, 96), we suspect that
inflammation plays an important role in SepH-deficient tumors.
The spectrum of tumors that we observed in the SepH-deficient
fish included PACC, HCC, cholangiocarcinoma, intestinal cancer,
and malignant spindle cell neoplasms, which resemble the MPNSTs
that arise spontaneously in tp53M214K mutant zebrafish (97).
Previous studies using Sec transfer RNA (tRNA) (trsp)-deficient
mice have greatly increased our understanding of selenoprotein
function. Germline disruption of trsp in mice leads to early em-
bryonic lethality (98). Tissue-specific loss of trsp in endothelial
cells, skin cells, osteochondroprogenitor cells, or neurons leads
to a panoply of defects that share such features as growth re-
tardation, degeneration, and premature death (99–103). Liver-
specific loss of trsp disrupts selenoprotein synthesis and causes
liver necrosis and death (104). Selenoprotein deficiency in the
liver activates the hepatoprotective Nrf2 response and increases
susceptibility to diethylnitrosamine (DEN)-induced tumorigen-
esis (101, 105, 106). Similarly, hematopoietic-specific loss of
selenoproteins leads to oxidative stress, hemolytic anemia, and
sustained activation of Nrf2 (107, 108). Prostate-specific trsp KO
mice exhibit prostate neoplasia, demonstrating that selenoproteins
function as tumor suppressors in the murine prostate (109, 110).
In a comparable manner, mammary gland- specific loss of trsp
renders mice susceptible to DMBA-induced tumorigenesis (111).
Gpx1/2 double-KO mice exhibit bacteria-induced inflamma-
tion (colitis) that spontaneously drives intestinal tumor formation
(112, 113). Gpx2 appears to play a complex role in colon carci-
nogenesis (114), where it inhibits inflammation-driven tumori-
genesis (115), yet promotes growth of xenografted tumors (116).
Loss of GPX2 leads to dedifferentiation of cells to a progenitor-
like state (117). Conversely, overexpression of GPX2 leads to cell
differentiation, with increased proliferation and tumor-forming
potential (117). Selenium status has a complex role in mouse
models of cancer, as demonstrated by studies showing that both
selenium deficiency and selenium supplementation can reduce
the tumor incidence in different mouse models (118, 119). Taken
together, these studies shed light on the complexity of the rela-
tionship between selenium status and tumorigenesis, while empha-
sizing the essential function of selenoproteins in maintaining tissue
homeostasis and suppressing tumorigenesis.
In conclusion, we have demonstrated that SepH regulates redox
homeostasis and plays an essential role in organ development and
tumor suppression. Given the potency by which SepH is regulated
by selenium intake, we propose that SepH deficiency contributes
to the deleterious phenotypes associated with selenium deficiency.
Experimental Procedures
Zebrafish Husbandry. Zebrafish were maintained according to Harvard Medi-
cal School Institutional Animal Care and Use Committee, protocol #04626.
The following lines were used in this study: WT (AB), sephhi2737Tg (seph mu-
tant), tp53zdf1 (p53M214K, loss of function) Tg(ela3l:EGFP;fabp10a:dsRed)gz15,
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Tg(gata6:GFP)ae5, and Tg(fabp2:dsRed )zf129, as described previously (29,
97, 120–123).
Chemical Exposure. Zebrafish larvae were exposed to menadione (1 μM),
camptothecin (1 μM), and DMBA (5 ppm), as described above. When nec-
essary, chemicals were dissolved in DMSO. Unless indicated otherwise, all
chemicals were obtained from Cayman Chemicals or Sigma-Aldrich.
Morpholino Injection. Morpholinos (GeneTools; PhiloMath) designed against
the ATG and site of SepH (5′- CGAGTCGCCATTGCAGCAGCAACAA-3′) or
scrambled controls were injected into AB embryos at the one-cell stage.
mRNA Rescue Experiment. SelH-GFP mRNA was synthesized using previously
described SelHSec38Cys-GFP or GFP-SelHSec38Cys mammalian expression constructs
(32, 33) as templates in conjunction with primers containing a T7 promoter
(GFP-SelHSec38Cys: forward primer, GGCTAATACGACTCACTATAGGATGGT-
GAGCAAGGGCGAGGA; reverse primer, GCTCTTTATGAAAGGTACTTCTTC;
SelHSec38Cys-GFP: forward primer, GGCTAATACGACTCACTATAGCATGGCC-
CCCCACGGAAGAAAG; reverse primer, GCTTTACTTGTACAGCTCGTC). SelHSec38Cys-
GFP or GFP-SelHSec38Cys mRNA was synthesized using the mMESSAGE mMACHINE
T7 Kit (Ambion). GFP mRNA was synthesized using pCS2-GFP as a template with
the mMESSAGE mMACHINE SP6 Transcription Kit (Ambion). Poly(A) tails
were added to mRNA using the Poly(A) Tailing Kit (Ambion) according to the
manufacturer’s instructions. GFP, SelHSec38Cys-GFP, or GFP-SelHSec38Cys mRNA
(100 ng/μL) was injected into seph mutant embryos (200 pg/egg) at the one-
cell stage. GFP-positive embryos were sorted at 1 dpf, and larvae were imaged
at 5 dpf. Individual larvae were subsequently genotyped using a three-primer
multiplex assay (5′-GAGCAGTTTAACAGTTTAGCAGCTTAAC-3′, 5′-CCATTGTTC-
AGTTCTGCTGTCAC-3′, and 5′-CTGTTCCATCTGTTCCTGAC-3′), which gave a
172-bp band (WT) and a 240-bp band (seph transgenic).
Whole-mount In Situ Hybridization. Paraformaldehyde (PFA)-fixed larvae were
processed for in situ hybridization according to standard zebrafish protocols
(www.zfin.org). The following RNA probes were used: seph, fabp10a, fabp2,
trypsin, and elav3. Expression patterns represent the average of >50 larvae
per treatment. Alternatively, the area of staining was analyzed using Fiji as
described previously (124).
Fluorescence Microscopy. Fluorescent liver and pancreas reporter [Tg(ela3l:
EGFP;fabp10a:dsRed)gz15], endoderm [Tg(gata6:GFP)ae5], or intestinal reporter
[Tg(fabp2:dsRed)zf129] larvae were put under anesthesia with 0.04 mg/mL
Tricaine-S, and microscopy was performed. Larvae were imaged using a Zeiss
Discovery V8/AxioCam MRc with the Axiovision software suite. Lightsheet
microscopy was performed using a Zeiss Lightsheet Z.1 at the Harvard Center
for Biological Imaging core. Fluorescent images were analyzed using Fiji as
described previously (124).
Steady-State Metabolomics Analysis.WT and sephmutant larvae were isolated
at 5 dpf, and methanol extraction was performed. Polar metabolites were
isolated and enriched using the methodology outlined by Yuan et al. (34).
Metabolite fractions were collected and analyzed by targeted LC-MS/MS via
SRMwith positive/negative ion polarity switching using a QTRAP (quadrupole-
linear ion trap) 5500 hybrid triple quadrupole mass spectrometer (AB Sciex).
RNA Transcriptomic Analysis. WT and seph mutant larvae were isolated at
5 dpf, and RNA was extracted with TRIzol (Life Technologies) according to
the manufacturer’s instructions. RNA quality was checked using an Agilent
2100 Bioanalyzer. Sequencing was performed after library construction on
an Illumina HiSeq. polyA sequence data were annotated on the ZV9 genomic
assembly to identify differentially affected genes (125). Gene Ontology and
GSEA of biological processes were determined by GAGE (Gene Ontology
Consortium) (126).
qRT-PCR. RNA was isolated from pooled zebrafish larvae using TRIzol. After
DNase treatment, cDNA was synthesized using the SuperScript III First-Strand
Synthesis Kit (Life Technologies). qRT-PCR was performed on biological
triplicates using an iCycler with iQ SYBR Green (Bio-Rad). Gene expressionwas
analyzed with ef1a as the reference gene (Table S1).
H2O2 Detection. H2O2 generation was examined in 5 dpf WT and sephmutant
larvae by exposure to 5 μM peroxyfluor-2 (PF2) (127) for 1 h at 28 °C. After
incubation, PF2-loaded larvae were washed, and fluorescence was imaged.
MSR Activity Assay. MsrA and MsrB activity was assayed from 5 dpf WT and
sephmutant larval lysates (500 μg) as described previously (128). In brief, the
reductions of dabsylated Met-R-SO and dabsylated Met-S-SO by lysates in
the presence of NADPH were quantified by HPLC.
BrdU Incorporation Assay. Proliferation was assessed in zebrafish larvae using
whole-mount immunohistochemistry to examine the incorporation of BrdU.
Larvae were immersed in 200 μg/mL BrdU (B-5002; Sigma-Aldrich) for 4 h
before fixation. Larvae were processed for whole-mount immunohisto-
chemistry, probed with anti-BrdU (Roche; clone 9318), and visualized using
HRP-conjugated secondary coupled with a 3,3’-diaminobenzidine (DAB)
substrate kit.
DNA Content Analysis. The cell cycle was examined in disaggregated zebrafish
larvae at 5 dpf by FACS analysis of DNA content. Larvae were disaggregated
by mechanical disruption with a small pestle in a tube in 200 μL of PBS
(10 larvae/tube). Cells were strained through a 35-μM nylon mesh, stained
with 10 μg/mL Hoechst 33342, and incubated in the dark for 30 min before
FACS analysis. DNA content (VioFL1) of individual cells defined the G0/G1
phase (n), the G2/M phase (2n), and the S phase (intermediate).
Alcian Blue Staining. PFA-fixed 5 dpf larvae were bleached in H2O2, stained in
Alcian blue solution [1% HCl, 70% (vol/vol) ethanol, 0.1% Alcian blue]
overnight, and rinsed in acidic ethanol.
Histology. PFA-fixed fish were paraffin-embedded, cut into serial sections,
and stained with hematoxylin and eosin using standard techniques.
Immunohistochemistry. Fixed tissue embedded in paraffin was serially sec-
tioned before immunohistochemical analysis. Slides were deparaffinized and
rehydrated before heat-induced antigen retrieval. Antigens were detected
using primary antibodies, such as anti-PCNA (Anaspec; AS-55421) and anti-
cleaved caspase-3 (Abcam; ab13847), in conjunction with an HRP/DAB (ABC)
detection kit (Abcam; ab64264) according to the manufacturer’s instructions
(R&D Systems).
Immunoblot Analysis. Larval extracts were prepared from 5 dpf WT and seph
mutant larvae. Lysates were resolved by SDS/PAGE and transferred electro-
phoretically onto nitrocellulose. Membranes were probed with anti-p53
(Abcam; ab77813) or anti–β-actin (Cell Signaling Technology; 4967) over-
night and then detected with secondary antibody conjugated with HRP.
Antibody complexes were visualized by enhanced chemiluminescence using
X-ray film.
DMBA-Induced Carcinogenesis. Here 3-wk-old p53−/− and p53−/−;SepH+/− fry
were exposed to DMBA dissolved in DMSO for 24 h, as described previously
(129). The next day, the fry were rinsed several times in aquariumwater before
being returned to the aquarium tanks. Fish were monitored closely for gas-
trointestinal tumor development over the next 12 mo (excluding fish with
ocular tumors). Fish with distended abdomens were dissected, and tumors
were confirmed and diagnosed by histological analysis by two independent
pathologists (K.J.E. and J.R.H.), who were blinded to the fish genotype.
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